Pfizer and BioNTech Challenge Moderna Patents for Corona Vaccine – Health

2023-08-29 07:18:39

Mainz/New York/Cambridge – The US pharmaceutical company Pfizer and its German partner BioNTech are applying for the cancellation of Moderna’s patents on the corona vaccination technology in the USA. The two patents are “unimaginably general” and cover a basic idea that has been “known for a long time,” the vaccine manufacturers said on Monday before the US Patent Office’s Board of Appeal. The drugmakers also filed opposition to a third, related Moderna patent.

1693293677
#Pfizer #BioNTech #Challenge #Moderna #Patents #Corona #Vaccine #Health

Photo of author

Alexandra Hartman Editor-in-Chief

Editor-in-Chief Prize-winning journalist with over 20 years of international news experience. Alexandra leads the editorial team, ensuring every story meets the highest standards of accuracy and journalistic integrity.

Typhoon Saola will leave heavy rains and winds in Taiwan on its way to China

Huawei launches the Mate 60 Pro, the first smartphone capable of making satellite calls

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.